Risk of primary infection and reinfection with respiratory syncytial virus.
about
Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiologyPharmacological management of acute bronchiolitisEvidence of a causal role of winter virus infection during infancy in early childhood asthmaRespiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunityA role for airway remodeling during respiratory syncytial virus infection.Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.Hyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in miceIn Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusGenetic association of TLR4 Asp299Gly, TLR4 Thr399Ile, and CD14 C-159T polymorphisms with the risk of severe RSV infection: a meta-analysisDevelopment of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesSystems biology from virus to humansAnimal models of respiratory syncytial virus infection and diseaseBiomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severityModulation of host adaptive immunity by hRSV proteinsImpact of respiratory syncytial virus: the nurse's perspectiveStructure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial VirusStructures of respiratory syncytial virus nucleocapsid protein from two crystal forms: details of potential packing interactions in the native helical formStructure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing AntibodyViral etiology of hospitalized acute lower respiratory infections in children under 5 years of age -- a systematic review and meta-analysis.Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western CountriesDefining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart DiseaseThymus activity measured by T-cell receptor excision circles in patients with different severities of respiratory syncytial virus infectionQuantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household studyRespiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virusRespiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial CulturesDiscovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F GlycoproteinRespiratory syncytial virus matrix protein induces lung epithelial cell cycle arrest through a p53 dependent pathwayChallenges and opportunities in developing respiratory syncytial virus therapeuticsDetermining the breadth of the respiratory syncytial virus-specific T cell responseAutocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus.The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein.In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivoRSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.Epidemiological and clinical data of hospitalizations associated with respiratory syncytial virus infection in children under 5 years of age in Spain: FIVE multicenter studyEfficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.The level and duration of RSV-specific maternal IgG in infants in Kilifi KenyaIncidence of Hospitalization for Respiratory Syncytial Virus Infection amongst Children in Ontario, Canada: A Population-Based Study Using Validated Health Administrative Data.Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresisA prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural IndiaA meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection
P2860
Q21133803-004EFD03-8E69-4574-AC1B-CDC0CF2C926BQ24650574-C4B29462-876A-48B8-96DA-0BA3B592A929Q24653420-D4CE88CB-4105-48ED-9293-68F7D64ED744Q24676109-D23F7228-403E-4DBB-BEE9-0D0B441914CFQ24810707-20415E92-313B-49EE-8F09-833F6CE81485Q24815873-529B8377-729A-49B6-A8A0-1DBA995926F9Q25256827-686E7D4A-D8F0-4099-B8AC-CB0FAAAD0FD7Q26748856-B55133C2-3FDD-4B50-891A-DC47EBA972E8Q26768424-C360B19C-A2BE-43AC-BD10-57B77E64B5ADQ26782411-31151234-DAB0-421D-9CAC-536EE180C421Q26798272-23D5390C-6B28-49A7-A0A1-B32A70686EE9Q26801458-A6B55A1F-148E-4DA9-AD0F-056198B41B3EQ27010165-09EFE459-4C11-42F0-B3FD-F5EF01CD0992Q27022693-A381AE35-9DDD-4907-AC8D-CA469D0755B4Q27023799-80451591-5295-4806-8670-7A56F7CF99E6Q27333522-D433FD9D-5217-430B-9C8B-4C72FE29951BQ27675688-5C671ADC-33AF-429F-A724-86D0A1F2D2FEQ27677570-A518C6C4-4945-4FF2-86E0-1429A74D0BBFQ27692099-D63686D5-A3CD-4187-9BD5-98AD13A35C83Q28069415-73C598AD-9489-47A7-A2B6-85486D723DC6Q28072535-C3CE43B1-34E6-494C-82E7-B28393C1653CQ28364937-91C2582F-94BB-4D54-AF01-DAADD33B9FA7Q28365074-78556D94-FC23-42AF-8F86-23B58B5BC003Q28545124-9D507754-B603-4F8C-8CA6-60874CEC8973Q28551477-8646FF64-304F-4EC2-B3C4-EE220B88EFBAQ28552644-676C8BF3-20A2-4344-91F3-F2C6F5E68528Q28729205-6102B8A7-62EB-4D59-A7B8-E27A973C6472Q30300567-7BF793E9-F232-4F5E-BFC4-12BFB30FBCFAQ30411070-14152805-CC9C-4E6F-8A19-C83244BB4200Q30431134-0CC6C8B4-FE67-4C38-AD8E-6412BCB9A1DFQ30440686-21B6FBAE-6359-4D81-B1D9-3A4A2D2B5337Q30512964-0F883324-07EE-42A3-967A-431409A3CC25Q30577192-4DF02129-7B26-4F6D-9D49-CADCA013795DQ30725005-DAEC2555-6674-4E78-88D4-13C17AE568E8Q30933288-5B767867-8F8B-4D15-8DD6-65C9D97AAB4FQ30941156-6CDD6080-1236-452D-B4AC-F05FB5B23AFFQ31055892-6DF7FE47-7B21-487E-BCE5-9511B89B985AQ31120475-00013BFC-2D16-460A-B1B3-7683A1C9865CQ33286812-5885C21A-1925-4BC8-80F1-006D9F744878Q33478019-89D469DC-3A85-424F-A27F-D5E6B2EF003A
P2860
Risk of primary infection and reinfection with respiratory syncytial virus.
description
1986 nî lūn-bûn
@nan
1986 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Risk of primary infection and reinfection with respiratory syncytial virus.
@ast
Risk of primary infection and reinfection with respiratory syncytial virus.
@en
Risk of primary infection and reinfection with respiratory syncytial virus.
@nl
type
label
Risk of primary infection and reinfection with respiratory syncytial virus.
@ast
Risk of primary infection and reinfection with respiratory syncytial virus.
@en
Risk of primary infection and reinfection with respiratory syncytial virus.
@nl
prefLabel
Risk of primary infection and reinfection with respiratory syncytial virus.
@ast
Risk of primary infection and reinfection with respiratory syncytial virus.
@en
Risk of primary infection and reinfection with respiratory syncytial virus.
@nl
P2093
P1476
Risk of primary infection and reinfection with respiratory syncytial virus.
@en
P2093
P304
P577
1986-06-01T00:00:00Z